This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Ventrus Biosciences(VTUS) is a specialty pharmaceutical company focused on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence. This stock is trading up 1.5% at $10.13 in recent trading.
Today's Volume: 120,000
Average Volume: 76,941
Volume % Change: 117%
From a technical perspective, VTUS is starting to bounce today right off its 50-day moving average of $10.10 with above average volume. This move is quickly pushing the stock within range of triggering a major near-term breakout trade. That trade will hit once VTUS takes out some near-term overhead resistance at $11.15 to $12 with high volume.
Traders should look for long-biased trades if VTUS can sustain a move and close over $11.15 to $12 with volume that's near or well above 76,941 shares. If we get that action today or soon, look for VTUS to make a run at $15 or higher in the near future.
To see more stocks rising on unusual volume, check out the
Stocks Rising On Unusual Volume portfolio on Stockpickr.
-- Written by Roberto Pedone in Winderemere, Fla.